Skip to content
Open access

Evidence of different predictors for different types of cardiotoxicities after hypo-fractionated whole breast radiotherapy

Jul 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 51 references
Medicine

TL;DR

CAC_corr events were mainly associated with CAC burden and age, independently of tumor laterality, as most occurred after left-sided irradiation, while MHD was not independently associated with cardiac events.

Abstract

Background and purpose Cardiac calcifications (CAC) are emerging as relevant predictors of cardiac toxicity after breast cancer radiotherapy. This study aimed to investigate the association between quantitative CAC scores and specific subgroups of cardiac events in patients treated with moderate hypofractionation, and to assess the interplay between dosimetric and clinical predictors for different families of events. Materials and methods Data from 1172 consecutive breast cancer patients treated at a single institution with 40 Gy in 15 fractions were analyzed. Mean heart dose (MHD) was extracted after automatic heart segmentation. Agatston score (AS), CAC volume, and maximum heart HU value (Max_HU) were quantified from planning CT scans. Available clinical variables included laterality, chemotherapy, age, smoking status, and respiratory toxicity occurring within 3 years after radiotherapy. Cardiac events were classified into two groups: CAC_corr (coronary artery disease, acute myocardial infarction, congestive heart failure, and valvular disease) and CAC_uncorr (conduction abnormalities, atrial premature beats, atrial fibrillation, pericarditis, and tachyarrhythmia). Associations between predictors and outcomes were tested using logistic regression. Results After excluding patients with pacemakers/electrodes, 1091 patients were available. With a median follow-up of 6.5 years, 29 cardiac events were recorded. Among them, 15/29 were CAC_corr and were similarly distributed between right-and left-sided tumors (8 vs 7). Conversely, 13/14 CAC_uncorr events occurred in left breast cancer patients; therefore, analyses for this subgroup were restricted to left-sided cases (13/561). For CAC_corr events, the combination of AS/CAC_volume/Max_HU with age showed the best predictive performance (AUC=0.80/0.79, p<0.0001), while respiratory toxicity had no impact. For CAC_uncorr events, age and anthracycline-based chemotherapy (FEC) were the strongest predictors (AUC=0.73, p=0.0125). Including respiratory toxicity significantly improved model performance (AUC=0.77, p=0.0003). MHD was not independently associated with cardiac events. Conclusion CAC_corr events were mainly associated with CAC burden and age, independently of tumor laterality. In contrast, CAC_uncorr events appeared more related to treatment-related factors, as most occurred after left-sided irradiation. Within left breast cancer patients, these events were mainly associated with age, anthracycline-based chemotherapy, and respiratory toxicity rather than with MHD.

Read PDF

Similar papers

Open access Aug 2026

Cardiac monitoring and incidence of cardiotoxicity cardiomyopathy among breast cancer patients undergoing anthracycline regimen chemotherapy: insight from a single centre study

Anthracyclines remain a cornerstone of breast cancer therapy but carry a significant risk of cancer therapy-related cardiac dysfunction (CTRCD). This study evaluates the incidence of CTRCD in an Indonesian setting using the latest 2022 ESC Cardio-Oncology guidelines, focusing on subclinical markers such as high-s...

Astri Astuti, Adila Aafiyah, Aurora Adila Arderia et al. · 0 citations
Open access Sep 2026

Evaluation of Cardiac Function After Stereotactic Body Radiation Therapy for Lung Tumors: Results of the Prospective Explorative Heart-Lung Study

Purpose Several studies show associations between cardiac radiation dose and cardiac morbidity or overall survival. To evaluate cardiac toxicity of radiation therapy in the absence of another cardiotoxic agent, we set up a prospective pilot study evaluating cardiac function using a wide range of diagnostic modalities i...

W. Hoeksema, J. Belderbos, E. Dieleman et al. · 0 citations
Open access Sep 2026

Spatial mapping of cardiac dose-survival associations in oesophageal radiotherapy.

PURPOSE To investigate spatial associations between cardiac radiation dose and survival following radiotherapy for oesophageal cancer, and to assess whether a previously defined Cardiac Avoidance Area (CAA) from lung radiotherapy is relevant in this patient population. MATERIALS AND METHODS Patients treated with cura...

T. Marchant, G. Radhakrishna, H. Sheikh et al. · 0 citations
Review Open access Sep 2026

Attributable fraction of cardiac disease following radiotherapy among breast cancer survivors: a systematic review and meta-analysis

ABSTRACT Radiotherapy (RT) is an integral component of cancer treatment; however, it can expose surrounding healthy tissues, including the heart, to ionizing radiation. This study aimed to evaluate the dose–response relationship between mean heart dose (MHD) and cardiac disease and to estimate the attributable burden a...

Jeeyoung Lee, Eun Jung Park, Eria Bwogi et al. · 0 citations
Review Open access Sep 2026

Ventricular Arterial Coupling as a Marker of Early Cardiotoxicity in Survivors of Childhood Cancer.

Improved childhood cancer survival has been accompanied by substantial late morbidity and mortality related to cardiotoxic cancer therapies. We conducted a retrospective study of childhood cancer survivors (CCS) diagnosed before age 21 and followed at The Children's Hospital at Montefiore (CHAM). Collected data include...

J. Wilcox, Leya Schwartz, J. Mahgerefteh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.